Amilpar - Press Release
RIO DE JANEIRO, Jan. 12 /PRNewswire-FirstCall/ -- Amilpar (BOVESPA: AMIL3, Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3 SA), the largest managed care organization in Brazil, in accordance with CVM (Brazilian Securities and Exchange Commission) Instruction 358/02, informs that was approved in Board Meeting held today, the 1st Issuance of Debentures for public distribution with restricted selling efforts (according to CVM Instruction 476/09), with the objective of increase Company's cash position after the acquisition of Medial Saude S.A. control, under the following terms and conditions:
Total Amount: R$ 300 million
Term: 360 days, with the option of anticipating redemption after 180 days
Remuneration: 109.75% of CDI (average interbank deposit rate in Brazil)
Issuance: January 26, 2010
Coordinators: Banco Itau BBA S.A. e HSBC CTVM S.A.
To access the .pdf version, visit our website at www.amilpar.com.br/ir.
IR Contacts:
Investor Relations
Phone.: +55 (21) 3805-1155
E-mail: [email protected]
www.amilpar.com.br/ir
SOURCE Amilpar
Share this article